Drug
Mkc-1 clinical trials
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 1998
How studies write it
Studies that test it under each name
Name
- MKC-1
- 9
Studies by the year they started
9 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
CASI Pharmaceuticals, Inc. (6) · Memorial Sloan Kettering Cancer Center (3)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic Agents source
Studies
Open first, then newest update. How each study uses mkc-1 is read from its arms, and is right about nine times in ten.
Testing it · 9
- Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid TumorCompletedPhase 1Memorial Sloan Kettering Cancer CenterNCT00003755Written as MKC-1
- Ro 31-7453 in Treating Patients With Metastatic Solid TumorsCompletedPhase 1Memorial Sloan Kettering Cancer CenterNCT00014365Written as MKC-1
- Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00016250Written as MKC-1
- Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung CancerCompletedPhase 1/2CASI Pharmaceuticals, Inc.NCT00408226Written as MKC-1
- A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial CancerCompletedPhase 2CASI Pharmaceuticals, Inc.NCT00607607Written as MKC-1
- Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic CancerCompletedPhase 2CASI Pharmaceuticals, Inc.NCT00568646Written as MKC-1
- Phase 1 Study of MKC-1 in Patients With Advanced CancerCompletedPhase 1CASI Pharmaceuticals, Inc.NCT00656461Written as MKC-1
- A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1CompletedPhase 2CASI Pharmaceuticals, Inc.NCT00306631Written as MKC-1
- A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic MalignanciesCompletedPhase 1CASI Pharmaceuticals, Inc.NCT00506402Written as MKC-1
Codes
What other systems call mkc-1 · ClinicalTrials.gg INT004686
- UNII (FDA) DNZ11VPY7QMKC-1Confirmed FDA, NLM, Wikidata
- Wikidata Q27276500mkc-1Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C2507MKC-1One source FDA
- DrugBank DB05608One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | DNZ11VPY7Q | MKC-1 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27276500 | mkc-1 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C2507 | MKC-1 | One source FDA |
| DrugBank | DB05608 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.